Answers are grounded in this paper and cite their sources.
Experimental treatment improved clinical efficacy and reduced antibiotics and infection rates in patients with mild basal ganglia hematomas, indicating its potential benefits.
Background Robot-assisted puncture and drainage have been increasingly popular as surgical interventions for moderate basal ganglia hematomas; nevertheless, there is scant clinical evidence of their effectiveness in patients with mild basal ganglia hematomas (hematoma volume ≤ 15 mL). This study examined the safety and efficacy of CTA and DTI combined with robot-assisted puncture and drainage for mild basal ganglia hematomas. Methods We analyzed the clinical data (general information, short-term efficacy, and long-term efficacy) of 104 patients with mild cerebral hematoma, of whom 62 opted for medicinal conservative treatment (control group) and 42 opted for CTA and DTI combined with robot-assisted puncture drainage (experimental group). Results Compared with the control group, patients in the experimental group had a shorter hospital stay, a lower incidence of pulmonary infections, and a significantly lower frequency of antibiotics and mannitol within 3 days after surgery. In addition, patients in the experimental group had a significantly lower amount of residual hematoma within 3 days after surgery, which was completely resolved after 7 days, significantly shorter than the average hematoma subsidence time of 21 days in the control group. The clinical efficacy of the experimental group was better than those of the control group at 30 days, 3 months and 1 year. Conclusion The management of mild basal ganglia hematomas by CTA and DTI combined with robot-assisted puncture drainage holds significant potential for clinical implementation.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: